Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.20.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical) - Convertible Notes Payable [Member]
3 Months Ended
Mar. 31, 2020
USD ($)
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Common stock issuable upon conversion, shares | shares 7,936,740
Common stock issuable upon conversion | $ $ 793,674
Beneficial ownership limitations percentage 4.99%